Back to search

Article

Fabrication of mRNA encapsulated Lipid nanoparticles using <i>State-of-the-art</i> SMART-MaGIC Technology and transfection <i>in vitro</i>

2024-05-21

Abstract excerpt

The messenger ribose nucleic acid (mRNA) in lieu of Corona virus of 2019 (COVID-19) vaccines were effectively delivered through Lipid nanoparticles (LNP) which were proved effective carriers for clinical applications. In the present work, mRNA (erythropoietin (EPO)) encapsulated LNPs were prepared using a next generation state-of-the-art patented Sprayed Multi Absorbed-droplet Reposing Technology (SMART) coupled...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7991bca4-4f85-5554-b077-7ff294b153b1
DOI
10.1101/2024.05.17.594777
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fabrication of mRNA encapsulated Lipid nanoparticles using <i>State-of-the-art</i> SMART-MaGIC Technology and transfection <i>in vitro</i>DOI 10.1101/2024.05.17.594777
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imagingSemantic proximity
Lipid Nanoparticle Delivery Systems to Enable mRNA-Based TherapeuticsSemantic proximity
The Platform Technology Approach to mRNA Product Development and RegulationSemantic proximity
Revealing a Correlation between Structure and <i>in vitro</i> Activity of mRNA Lipid NanoparticlesSemantic proximity
Conventional and microfluidic methods: Design and optimization of lipid-polymeric hybrid nanoparticles for gene therapySemantic proximity
mRNA Vaccine Platforms and Lipid Nanoparticle Delivery Systems: Molecular Advances, Clinical Breakthroughs, and Regulatory Perspectives (2020–2025)Semantic proximity
Synthesis of mRNA lipid nanoparticles for engineering GD2 CAR T and CAR NK cells against neuroblastomaSemantic proximity
From COVID-19 to Global Health: Challenges and Opportunities in mRNA Vaccine ProductionSemantic proximity
Clinical progress of nanomedicine-based RNA therapiesSemantic proximity
Transfection Technologies for Next-Generation TherapiesSemantic proximity
Enabling mRNA Therapeutics: Current Landscape and Challenges in ManufacturingSemantic proximity
mRNA vaccines in the prevention and treatment of diseasesSemantic proximity
Select a neighboring publication to make it the new centre.